CELLONTECH

• 2020

  • 「CartiFill」 CSDT per AMDD (ASEAN Medical Device Directive) submitted to HAS (Health Sciences Authority) Singapore

  • ISO 13485:2016 (Quality Management System) certified

• 2019

  • National health insurance coverage for 「Chondron」 expanded, groundbreaking ceremony for ‘RMS CAMP’ and proclamation ceremony for ‘RMS Innovation 2028’ global vision held

• 2018

  • 「Chondron」 kicked off Phase 3 clinical trials in Japan, ‘Regenerative Medical System Center for Innovation’ established

• 2017

  •

  'Theraform-D' preclinical research conducted jointly with Columbia University 

  •

  Awarded the 'Research Poster' from ICOI (International Congress of Oral Implantologists) 

  •

  「RegenPatch」 gained marketing approval from the Ministry of Food and Drug Safety (MFDS) of Korea 

  •

  Selected as ‘2016 Biopharmaceutical Industrial Development Contribution Corporation’ and awarded the ‘Minister of Health and Welfare Accolade’ 

  •

  'ATELOCOLLAGEN-D.F.' registered in FDA DMF (Drug Master Files)

  • Selected as one of 52 delegation to accompany the President's visit to the White House

• 2016

  • 「CartiZol」 acquried NET (New Excellent Technology) cert.

  • 'ATELOCOLLAGEN-D.F.' registered in ICID (International Cosmetic Ingredient Dictionary and Handbook) of PCPC (The Personal Care Products Council)